INTRODUCTION
Recent advances in Novel Drug Delivery System (NDDS) aims to enhance safety and efficacy of drug molecule by formulating a convenient dosage form for administration and to achieve better patient compliance. One such approach is Fast Dissolving Tablet (ODT). [1] [2] [3] [4] The term ODT appears in the European Pharmacopoeia defined as ''uncovered tablet for buccal cavity, where it disperses before ingestion". The solid ODT dosage form turns into a soft paste or liquid form for easy swallowing, and thus it is free of suffocation risk. ODTs are beneficial for paediatric, geriatric, schizophrenic, bedridden patients and those with Parkinsonism or developmentally disabled patients with persistent nausea and patients who have little or no access to water. ODT will avoid missing out of dose even during travelling, busy or other situations where there is no access to water. They undergo disaggregation in the mouth when in contact with the saliva in less than 60 seconds, preferably in less than 40 seconds, forming a suspension which is easy to swallow. A major claim of some oral dispersible tablets is increased bioavailability compared to traditional tablets because some of the drugs are absorbed from the mouth, pharynx and esophagus as the saliva passes down into the stomach. In such cases, the bioavailability of the drug is significantly increased over those observed in the conventional tablet dosage form.
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MATERIALS AND METHODS
Sublimation method
Specified quantity of Cinnarizine, camphor, mannitol, aspartame, talc and magnesium stearate were weighed accurately and were passed through 60 # screen prior to mixing. All the materials were transferred to mortar and triturated till it mixed uniformly. The resulting powder mixture was compressed into tablets using single punch tablet machine. The tablets were dried at 60 o C oven till constant weigh obtained. 
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EVALUATION OF POWDER BLEND
In-vitro Disintegration time
The in-vitro disintegration time was determined using disintegration test apparatus. A tablet was placed in each of the six tubes of the apparatus and one disc was added to each tube. The time in seconds taken for complete disintegration of the tablet with no palatable mass remaining in the apparatus was measured in seconds. The disintegration time and friability were evaluated and results were graphically summarized in the Figure 1 and Figure 2 The friability of tablets, prepared by various methods was shown in Fig. No 1 . Friability of all batches was in the range of standard limit (less than 1%) and no more significant difference. It can be concluded that tablets prepared by superdisintegrant addition method has less disintegration time than other method.
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STUDY OF THE EFFECT OF CONCENTRATION OF AVICEL PH 102
The intermediate concentration of the diluent (Avicel PH 102), that is, 20 -50 % of the tablet weight was selected from the trial series. These trial batches were prepared by super disintegrant addition method with same process as above. All the quantities are in mg.
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These tablets were evaluated for hardness, friability and disintegration time. The procedure was same as above evaluation tests. The friability and disintegration time were evaluated and results are graphically summarized in the 
In-Vitro drug release:
Release of the drug in vitro, was determined by estimating the dissolution profile.
Dissolution test:
Standard USP or IP dissolution apparatus have been used to study in vitro release profile using rotating paddle.In vitro release rate study of mouth dissolving tablet of Cinnarizine was carried out using the Apparatus 2 (Paddle apparatus) method. The dissolution apparatus was covered with the black color polythine to protect the solution from light. The dissolution test was carried out using 900 ml of 0.1 N HCl, at 37 + 0.5 0 C and 50 rpm. A sample (5 ml) of the solution was withdrawn from the dissolution apparatus at 2, 4, 6, 8 and 10 min and withdrawn volume was replaced with fresh dissolution media. [18] [19] [20] The withdrawn samples diluted with dissolution medium and then filter it with whattman filter paper and assayed at 253.5 nm. The % release of Cinnarizine was calculated. 
COMPARISON OF BEST FORMULATED TABLET WITH MARKETED TABLET
The best formulated tablet was then compared with marketed tablet STUGERON 25mg. Formulation B9 was compared with marketed tablet for in vitro dissolution study. 
SUMMARY AND CONCLUSION
The present study was undertaken with an aim to formulate and evaluate Fast Dissolving tablets of Cinnarizine using Sublimation method with the addition of superdisintegranting agents. To increase the dissolution rate of poorly soluble drug Cinnarizine, by using the addition of Avicel 102 as Superdisintegrants. Preformulation study was carried out initially and results directed for the further course of formulation. Various formulations of Fast Dissolving tablets Cinnarizine were formulated by using various super Disintegrants-
